Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.
Bacillus Calmette Guerin
Chronic Granulomatous Disease
India
Mycobacterium tuberculosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
11
2020
accepted:
06
01
2021
entrez:
15
3
2021
pubmed:
16
3
2021
medline:
4
8
2021
Statut:
epublish
Résumé
Chronic granulomatous disease (CGD) is an inherited defect in phagocytic respiratory burst that results in severe and life-threatening infections in affected children. Single center studies from India have shown that proportion of autosomal recessive (AR) CGD is more than that reported from the West. Further, affected patients have high mortality rates due to late referrals and difficulties in accessing appropriate treatment. However, there is lack of multicentric collaborative data on CGD from India. To describe infection patterns, immunological, and molecular features of CGD from multiple centers in India. A detailed proforma that included clinical and laboratory details was prepared and sent to multiple centers in India that are involved in the care and management of patients with inborn errors of immunity. Twelve centers have provided data which were later pooled together and analyzed. Of the 236 patients analyzed in our study, X-linked and AR-CGD was seen in 77 and 97, respectively. Male female ratio was 172:64. Median age at onset of symptoms and diagnosis was 8 and 24 months, respectively. Common infections documented include pneumonia (71.6%), lymphadenitis (31.6%), skin and subcutaneous abscess (23.7%), blood-stream infection (13.6%), osteomyelitis (8.6%), liver abscess (7.2%), lung abscess (2.9%), meningoencephalitis (2.5%), splenic abscess (1.7%), and brain abscess (0.9%). Forty-four patients (18.6%) had evidence of mycobacterial infection. Results of molecular assay were available for 141 patients (59.7%)- In India, proportion of patients with AR-CGD is higher as compared to Western cohorts, though regional differences in types of AR-CGD exist. Clinical profile and mortality rates are similar in both X-linked and AR-CGD. However, this may be a reflection of the fact that milder forms of AR-CGD are probably being missed.
Sections du résumé
Background
Chronic granulomatous disease (CGD) is an inherited defect in phagocytic respiratory burst that results in severe and life-threatening infections in affected children. Single center studies from India have shown that proportion of autosomal recessive (AR) CGD is more than that reported from the West. Further, affected patients have high mortality rates due to late referrals and difficulties in accessing appropriate treatment. However, there is lack of multicentric collaborative data on CGD from India.
Objective
To describe infection patterns, immunological, and molecular features of CGD from multiple centers in India.
Methods
A detailed proforma that included clinical and laboratory details was prepared and sent to multiple centers in India that are involved in the care and management of patients with inborn errors of immunity. Twelve centers have provided data which were later pooled together and analyzed.
Results
Of the 236 patients analyzed in our study, X-linked and AR-CGD was seen in 77 and 97, respectively. Male female ratio was 172:64. Median age at onset of symptoms and diagnosis was 8 and 24 months, respectively. Common infections documented include pneumonia (71.6%), lymphadenitis (31.6%), skin and subcutaneous abscess (23.7%), blood-stream infection (13.6%), osteomyelitis (8.6%), liver abscess (7.2%), lung abscess (2.9%), meningoencephalitis (2.5%), splenic abscess (1.7%), and brain abscess (0.9%). Forty-four patients (18.6%) had evidence of mycobacterial infection. Results of molecular assay were available for 141 patients (59.7%)-
Conclusions
In India, proportion of patients with AR-CGD is higher as compared to Western cohorts, though regional differences in types of AR-CGD exist. Clinical profile and mortality rates are similar in both X-linked and AR-CGD. However, this may be a reflection of the fact that milder forms of AR-CGD are probably being missed.
Identifiants
pubmed: 33717137
doi: 10.3389/fimmu.2021.625320
pmc: PMC7946827
doi:
Substances chimiques
NADPH Oxidase 2
EC 1.6.3.-
NADPH Oxidases
EC 1.6.3.-
NCF2 protein, human
EC 1.6.3.1
neutrophil cytosolic factor 1
EC 1.6.3.1
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
625320Informations de copyright
Copyright © 2021 Rawat, Vignesh, Sudhakar, Sharma, Suri, Jindal, Gupta, Shandilya, Loganathan, Kaur, Chawla, Patra, Khadwal, Saikia, Minz, Aggarwal, Taur, Pandrowala, Gowri, Desai, Kulkarni, Hule, Bargir, Kambli, Madkaikar, Bhattad, Ginigeri, Kumar, Jayaram, Munirathnam, Sivasankaran, Raj, Uppuluri, Na, George, Lashkari, Kalra, Sachdeva, Seth, Sabui, Gupta, van Leeuwen, de Boer, Chan, Imai, Ohara, Nonoyama, Lau and Singh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Am J Hematol. 2017 Jan;92(1):28-36
pubmed: 27701760
Eur J Pediatr. 1991 Jan;150(3):161-5
pubmed: 2044584
Science. 1968 Dec 13;162(3859):1277-9
pubmed: 4387010
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):E59-67
pubmed: 22203994
J Clin Immunol. 2017 Apr;37(3):319-328
pubmed: 28332028
Pediatr Allergy Immunol. 2019 May;30(3):378-386
pubmed: 30716179
J Allergy Clin Immunol Pract. 2021 Feb;9(2):771-782.e3
pubmed: 33259975
J Clin Invest. 2018 Aug 31;128(9):3957-3975
pubmed: 29969437
Pediatrics. 2004 Aug;114(2):462-8
pubmed: 15286231
J Clin Immunol. 2019 Aug;39(6):611-615
pubmed: 31338742
J Clin Immunol. 2021 Feb;41(2):393-413
pubmed: 33225392
Pediatr Infect Dis J. 2016 Sep;35(9):1043-5
pubmed: 27182896
Front Immunol. 2019 Jun 11;10:1248
pubmed: 31244832
J Neuroimmunol. 2020 Jun 15;343:577229
pubmed: 32247876
J Clin Immunol. 2020 Apr;40(3):475-493
pubmed: 32040803
Southeast Asian J Trop Med Public Health. 2010 Mar;41(2):401-9
pubmed: 20578524
J Clin Immunol. 2014 Jan;34(1):58-67
pubmed: 24276928
Clin Infect Dis. 2015 Apr 15;60(8):1176-83
pubmed: 25537876
J Clin Immunol. 2021 Feb;41(2):486-490
pubmed: 33216270
J Clin Immunol. 2021 Apr;41(3):552-564
pubmed: 33387158
J Clin Immunol. 2018 Nov;38(8):898-916
pubmed: 30470980
Blood Cells Mol Dis. 2010 Oct 15;45(3):246-65
pubmed: 20729109
Int Arch Allergy Immunol. 2020 Oct 15;:1-4
pubmed: 33059354
Clin Infect Dis. 2012 Mar 1;54(5):694-700
pubmed: 22157170
Medicine (Baltimore). 2000 May;79(3):155-69
pubmed: 10844935
Hum Mutat. 2008 Sep;29(9):E132-49
pubmed: 18546332
Front Immunol. 2019 Sep 11;10:2111
pubmed: 31572360
Semin Immunopathol. 2008 Jul;30(3):255-71
pubmed: 18509648
Br Med Bull. 2016 Jun;118(1):50-63
pubmed: 26983962
Pediatr Pathol. 1990;10(1-2):143-53
pubmed: 2107536
Asian Pac J Allergy Immunol. 2013 Sep;31(3):217-26
pubmed: 24053704
J Clin Immunol. 2011 Oct;31(5):792-801
pubmed: 21789723
Clin Exp Immunol. 2008 May;152(2):211-8
pubmed: 18410635
J Clin Immunol. 2016 Nov;36(8):774-784
pubmed: 27699571
Allergol Immunopathol (Madr). 2015 May-Jun;43(3):279-85
pubmed: 25796307
Lancet. 1972 May 6;1(7758):1024
pubmed: 4112355
Pediatr Blood Cancer. 2015 Dec;62(12):2101-7
pubmed: 26185101
J Clin Immunol. 2018 Apr;38(3):260-272
pubmed: 29560547
Minn Med. 1957 May;40(5):309-12
pubmed: 13430573
J Clin Immunol. 2017 Feb;37(2):109-112
pubmed: 28035544
J Allergy Clin Immunol. 2013 Nov;132(5):1156-1163.e5
pubmed: 23910690
Br J Haematol. 2011 Aug;154(3):363-72
pubmed: 21569009
J Immunol Methods. 1990 Aug 7;131(2):269-75
pubmed: 2391431
Immunol Rev. 1994 Apr;138:121-57
pubmed: 8070813
PLoS One. 2009;4(4):e5234
pubmed: 19381301
N Engl J Med. 1968 May 2;278(18):971-6
pubmed: 4384563
Nature. 1987 Mar 5-11;326(6108):88-91
pubmed: 3821877
Lancet. 1969 Jan 18;1(7586):157
pubmed: 4178273
Blood Cells Mol Dis. 2010 Apr 15;44(4):291-9
pubmed: 20167518
Nat Commun. 2018 Oct 25;9(1):4447
pubmed: 30361506
Blood. 2000 Aug 1;96(3):1106-12
pubmed: 10910929
Clin Infect Dis. 2010 Dec 15;51(12):1429-34
pubmed: 21058909
Br J Haematol. 2000 Mar;108(3):511-7
pubmed: 10759707
J Clin Immunol. 2019 Nov;39(8):762-775
pubmed: 31456102